INNATE PHARMA |
Market Closed -
Other stock markets
|
After market 01:13:54 pm | |||
| 2.525 EUR | -0.20% |
|
2.513 | -0.48% |
| May. 24 | Innate Pharma: five abstracts selected for ASCO | CF |
| May. 14 | Transcript : Innate Pharma S.A., Q1 2024 Earnings Call, May 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INNATE PHARMA | Other Biotechnology & Medical Research | -0.20% | -4.17% | -3.63% | -11.09% | -57.85% | 222M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IPH Stock
- Charts Innate Pharma
- Comparison Chart
